SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nunzia Pharmaceutical Co. – ‘10-Q’ for 3/31/22 – ‘EX-101.SCH’

On:  Monday, 5/23/22, at 7:33am ET   ·   For:  3/31/22   ·   Accession #:  1683168-22-3887   ·   File #:  1-39175

Previous ‘10-Q’:  ‘10-Q/A’ on 3/29/22 for 9/30/21   ·   Next:  ‘10-Q’ on 10/3/22 for 6/30/22   ·   Latest:  ‘10-Q’ on 11/14/22 for 9/30/22   ·   2 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/23/22  Nunzia Pharmaceutical Co.         10-Q        3/31/22   30:1.3M                                   GlobalOne Filings Inc/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    225K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     15K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     15K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     12K 
10: R1          Cover                                               HTML     59K 
11: R2          Consolidated Balance Sheets (Unaudited)             HTML     74K 
12: R3          Consolidated Balance Sheets (Unaudited)             HTML     22K 
                (Parenthetical)                                                  
13: R4          Consolidated Statements of Operations (Unaudited)   HTML     90K 
14: R5          Consolidated Statements of Cash Flows (Unaudited)   HTML     53K 
15: R6          Basis of Presentation, Organization, Going Concern  HTML     21K 
                and Recent Accounting Pronouncements                             
16: R7          Summary of Significant Accounting Policies          HTML     30K 
17: R8          Preferred and Common Stock                          HTML     22K 
18: R9          Commitments and Contingencies                       HTML     18K 
19: R10         Transactions with Related Persons                   HTML     18K 
20: R11         Subsequent Events                                   HTML     14K 
21: R12         Summary of Significant Accounting Policies          HTML     57K 
                (Policies)                                                       
22: R13         Basis of Presentation, Organization, Going Concern  HTML     15K 
                and Recent Accounting Pronouncements (Details                    
                Narrative)                                                       
23: R14         Summary of Significant Accounting Policies          HTML     14K 
                (Details Narrative)                                              
24: R15         Preferred and Common Stock (Details Narrative)      HTML     32K 
25: R16         Transactions with Related Persons (Details          HTML     26K 
                Narrative)                                                       
28: XML         IDEA XML File -- Filing Summary                      XML     44K 
26: XML         XBRL Instance -- nunzia_i10q-033122_htm              XML    203K 
27: EXCEL       IDEA Workbook of Financial Reports                  XLSX     30K 
 6: EX-101.CAL  XBRL Calculations -- nunz-20220331_cal               XML     51K 
 7: EX-101.DEF  XBRL Definitions -- nunz-20220331_def                XML    112K 
 8: EX-101.LAB  XBRL Labels -- nunz-20220331_lab                     XML    274K 
 9: EX-101.PRE  XBRL Presentations -- nunz-20220331_pre              XML    213K 
 5: EX-101.SCH  XBRL Schema -- nunz-20220331                         XSD     39K 
29: JSON        XBRL Instance as JSON Data -- MetaLinks              126±   162K 
30: ZIP         XBRL Zipped Folder -- 0001683168-22-003887-xbrl      Zip     54K

‘EX-101.SCH’   —   XBRL Schema — nunz-20220331

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaSPyaPty552CYkxvmRyfakKHykq5dU3tSYXXDgGIc8P -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:NUNZ="http://nunziapharma.com/20220331" elementFormDefault="qualified" targetNamespace="http://nunziapharma.com/20220331">
<annotation>
<appinfo>
<link:roleType roleURI="http://nunziapharma.com/role/Cover" id="Cover">
<link:definition> 00000001 - Document - Cover </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/BalanceSheets" id="BalanceSheets">
<link:definition> 00000002 - Statement - Consolidated Balance Sheets (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
<link:definition> 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/StatementsOfOperations" id="StatementsOfOperations">
<link:definition> 00000004 - Statement - Consolidated Statements of Operations (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
<link:definition> 00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncements" id="BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncements">
<link:definition> 00000006 - Disclosure - Basis of Presentation, Organization, Going Concern and Recent Accounting Pronouncements </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition> 00000007 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/PreferredAndCommonStock" id="PreferredAndCommonStock">
<link:definition> 00000008 - Disclosure - Preferred and Common Stock </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 00000009 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/TransactionsWithRelatedPersons" id="TransactionsWithRelatedPersons">
<link:definition> 00000010 - Disclosure - Transactions with Related Persons </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition> 00000011 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 00000012 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncementsDetailsNarrative" id="BasisOfPresentationOrganizationGoingConcernAndRecentAccountingPronouncementsDetailsNarrative">
<link:definition> 00000013 - Disclosure - Basis of Presentation, Organization, Going Concern and Recent Accounting Pronouncements (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
<link:definition> 00000014 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/PreferredAndCommonStockDetailsNarrative" id="PreferredAndCommonStockDetailsNarrative">
<link:definition> 00000015 - Disclosure - Preferred and Common Stock (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://nunziapharma.com/role/TransactionsWithRelatedPersonsDetailsNarrative" id="TransactionsWithRelatedPersonsDetailsNarrative">
<link:definition> 00000016 - Disclosure - Transactions with Related Persons (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="nunz-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="nunz-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="nunz-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="nunz-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
<import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
<import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
<import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
<import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
<element id="NUNZ_ClassACommonStockMember" name="ClassACommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="NUNZ_ClassBCommonStockMember" name="ClassBCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="NUNZ_CommonStockPayableMember" name="CommonStockPayableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="NUNZ_MichaelMitsunagaMember" name="MichaelMitsunagaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="NUNZ_CommonStockPayable" name="CommonStockPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="NUNZ_ManagementsRepresentationOfInterimFinancialStatementsPolicyTextBlock" name="ManagementsRepresentationOfInterimFinancialStatementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="NUNZ_RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock" name="RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
</schema>

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/04/21  Nunzia Pharmaceutical Co.         8-K©:1      8/03/21    1:27K                                    1562884
 5/07/21  Nunzia Pharmaceutical Co.         8-K©:1      4/12/21    1:337K                                   1562884
↑Top
Filing Submission 0001683168-22-003887   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 12:17:47.1am ET